TY  - GEN
AU  - Evans,Elizabeth E
AU  - Jonason,Alan S
AU  - Bussler,Holm
AU  - Torno,Sebold
AU  - Veeraraghavan,Janaki
AU  - Reilly,Christine
AU  - Doherty,Michael A
AU  - Seils,Jennifer
AU  - Winter,Laurie A
AU  - Mallow,Crystal
AU  - Kirk,Renee
AU  - Howell,Alan
AU  - Giralico,Susan
AU  - Scrivens,Maria
AU  - Klimatcheva,Katya
AU  - Fisher,Terrence L
AU  - Bowers,William J
AU  - Paris,Mark
AU  - Smith,Ernest S
AU  - Zauderer,Maurice
TI  - Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
SN  - 2326-6074
PY  - 2016///0224
KW  - Animals
KW  - Antibodies, Blocking
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antigen-Presenting Cells
KW  - immunology
KW  - Antigens, CD
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Breast Neoplasms
KW  - CTLA-4 Antigen
KW  - antagonists & inhibitors
KW  - Cell Line, Tumor
KW  - Cyclophosphamide
KW  - Cytokines
KW  - metabolism
KW  - Disease Models, Animal
KW  - Drug Synergism
KW  - Female
KW  - Humans
KW  - Immunologic Memory
KW  - Immunomodulation
KW  - drug effects
KW  - Immunotherapy
KW  - Lymphocyte Subsets
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Mice
KW  - Neoplasms
KW  - Programmed Cell Death 1 Receptor
KW  - Receptor, ErbB-2
KW  - Semaphorins
KW  - Tumor Burden
KW  - Tumor Microenvironment
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/2326-6066.CIR-14-0171
ER  -